PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Higher buprenorphine doses associated with improved retention in treatment for opioid use disorder

NIH-funded study suggests need to reevaluate opioid addiction treatment recommendations in the era of fentanyl

2023-09-18
(Press-News.org) Individuals with opioid use disorder who were prescribed a lower buprenorphine dose were 20% more likely to discontinue treatment than those on a higher dose, according to a study of patients prescribed buprenorphine in Rhode Island from 2016 to 2020, as fentanyl became widely available. The study, published today in JAMA Network Open, was supported by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, and conducted by researchers at Brown University, Providence, Rhode Island; NIDA and the Rhode Island Department of Health.

Among patients newly initiating buprenorphine treatment for opioid use disorder, 59% of those prescribed the target daily dose of 16 milligrams recommended by the U.S. Food and Drug Administration and 53% of those prescribed the higher 24 mg daily dose discontinued treatment within 180 days. A statistical analysis that allowed for multivariable comparison of these two dose groups showed patients prescribed the recommended dose (16 mg) were significantly more likely to discontinue treatment over 180 days compared to those prescribed 24 mg.

Medications for opioid use disorder such as buprenorphine can safely and effectively support reduction in opioid use and overdose as well as recovery by decreasing opioid cravings and easing withdrawal symptoms. These findings build upon accumulating evidence of the safety and efficacy of higher doses of buprenorphine. Studies have shown that more than 16 mg of buprenorphine is safe and well tolerated in people with opioid use disorder in emergency department and outpatient treatment settings.

“Effective treatment can save lives, but our proven treatments for opioid use disorders must evolve to match the challenges posed by the fentanyl crisis,” said NIDA Director, Nora Volkow, M.D. “If science continues to demonstrate that a higher dosage of buprenorphine increases treatment retention, we must re-evaluate clinical guidelines to optimize treatment and help people achieve recovery.”

In 2021, of nearly 107,000 overdose deaths reported, more than 70,000 were primarily due to fentanyl, a synthetic opioid that is approximately 50 times stronger than heroin. The ubiquity of fentanyl in the drug supply and resulting overdose death rate increase have raised questions about whether existing dosing guidelines for buprenorphine should be modified to better address the unique challenges posed by such a potent opioid. Currently, labeling approved by the FDA states that maintenance doses should range from 4 mg to 24 mg, with a recommended target dose of 16 mg per day for most patients. Recommended doses for treatment can also vary widely depending on the individual’s needs and response to the medication.

In this study, researchers retrospectively examined data from a statewide population of 6,499 Rhode Island residents initiating buprenorphine as part of treatment for opioid use disorder from 2016 to 2020, a period of fentanyl emergence and predominance. The goal was to estimate the association between patients’ daily buprenorphine dose and retention in treatment over 180 days, a time frame which aligns with the minimum treatment period considered by the U.S. Centers for Medicare and Medicaid Services to measure treatment continuity for opioid use disorder.

Most patients were aged 25 to 44 years, were male, and had private or Medicaid insurance. At initiation of buprenorphine treatment, approximately 21% (1,343 patients) were prescribed 8 mg, 50% (3,264 patients) 16 mg, and 10% (668 patients) 24 mg. Those prescribed more than 24 mg were unable to be analyzed due to the small number (0.2%, or 15 patients) prescribed such doses during the study period.

Patients prescribed a 24 mg dose of buprenorphine were retained in treatment for a longer period than those prescribed the recommended target maintenance dose of 16 mg. A statistical analysis showed the latter group was 20% more likely to discontinue treatment than those prescribed 24 mg.

“The current recommended target dose of buprenorphine was derived from studies conducted prior to the widespread availability of fentanyl. Now, we’re seeing people with higher levels of tolerance to and dependence on opioids, and our findings suggest that a higher buprenorphine dose – up to 24 mg – may help improve treatment retention for these individuals,” said Rachel Wightman, M.D., Associate Professor of Emergency Medicine and Epidemiology at Alpert Medical School of Brown University and one of the principal investigators of the study. “We have a responsibility to set patients up for success.”

To continue this research, scientists aim to conduct a prospective randomized clinical trial to assess the impact of daily buprenorphine doses up to 24 mg in improving treatment retention and reducing the risk of overdose and death. Within this trial, the researchers will also investigate the role of other factors that may be associated with treatment retention, including clinician prescribing practices, as well as patient socio-demographics and life circumstances. Findings from this trial could ultimately help inform updates to opioid use disorder treatment standards.

---------------------------------------------

For more information on substance and mental health treatment programs in your area, call the free and confidential National Helpline 1-800-662-HELP (4357) or visit www.FindTreatment.gov. 

Reference: LC Chambers, et al. Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl. JAMA Network Open. DOI: 10.1001/jamanetworkopen.2023.34540 (2023)

 

###


About the National Institute on Drug Abuse (NIDA): NIDA is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world’s research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science. For more information about NIDA and its programs, visit www.nida.nih.gov.

About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

 

About substance use disorders: Substance use disorders are chronic, treatable conditions from which people can recover. In 2021, over 46 million people in the United States had at least one substance use disorder. Substance use disorders are defined in part by continued use of substances despite negative consequences. They are also relapsing conditions, in which periods of abstinence (not using substances) can be followed by a return to use. Stigma can make individuals with substance use disorders less likely to seek treatment. Using preferred language can help accurately report on substance use and addiction. View NIDA’s online guide.

 

NIH…Turning Discovery Into Health®

 

###

END



ELSE PRESS RELEASES FROM THIS DATE:

Tracking down the formation of cardenolides in plants

Tracking down the formation of cardenolides in plants
2023-09-18
Plants produce an impressive array of metabolites, including many medically valuable steroids. Well-known examples of this class of substances obtained from plants are cardenolides. As early as 1785, the British physician William Withering (1741-1799) published a book on the red foxglove and its use in medicine (An account of the foxglove, and some of its medical uses: with practical remarks on dropsy, and other diseases. Birmingham 1785).  He had found out in experiments that taking extracts ...

The surprising origin of a deadly hospital infection

2023-09-18
Hospital staff spend a significant amount of time working to protect patients from acquiring infections while they are being cared for in the hospital. They employ various methods from hand hygiene to isolation rooms to rigorous environmental sanitation. Despite these efforts, hospital-onset infections still occur—the most common of which is caused by the bacterium Clostridioides difficile, or C. diff, the culprit of almost half a million infections in the U.S. each year. Surprising findings from a new study in Nature Medicine suggest that the burden of C. diff infection may be less a matter of hospital transmission and more a result of characteristics associated ...

Mature sperm lack intact mitochondrial DNA, study finds

2023-09-18
New research provides insight about the bedrock scientific principle that mitochondrial DNA — the distinct genetic code embedded in the organelle that serves as the powerplant of every cell in the body — is exclusively passed down by the mother. The study, a collaboration among Oregon Health & Science University and other institutions, published today in the journal Nature Genetics. Scientists have long recognized the fact that mitochondrial DNA, or mtDNA, comes exclusively from egg cells in humans, meaning only the mother contributes the genetic code carried by ...

Research identifies new potential hurdle for nano-based therapies

Research identifies new potential hurdle for nano-based therapies
2023-09-18
HOUSTON ― Researchers at The University of Texas MD Anderson Cancer Center have discovered that certain nano-based cancer therapies may be less effective in younger patients, highlighting the need for further investigation into the impact of aging on the body’s ability to respond to treatment. The researchers found age-related differences are due to how effectively the liver filters the bloodstream. Younger livers are more efficient at this process, which helps limit toxins in the blood but also filters out beneficial treatments, potentially rendering them ineffective. The study, published today in ...

Improving the properties of sweeteners for enhanced thermal energy storage

Improving the properties of sweeteners for enhanced thermal energy storage
2023-09-18
As we seek more efficient utilization of waste thermal energy, use of “phase change materials (PCMs)” is a good option. PCMs have a large latent heat capacity and the ability to store-and-release heat as they change from one state of matter to another. Among many PCMs, sugar alcohols (SAs), a class of organic compounds commonly used as sweeteners, stand out due to their low cost, non-toxic, non-corrosive, and biodegradable nature. In particular, SAs generally have their melting point in 100–200 °C, which is an important temperature range where a huge amount of waste heat exists but is currently ...

Ohio State leads new global climate center on AI for biodiversity change

2023-09-18
COLUMBUS, Ohio – The Ohio State University will lead a new multimillion dollar international center devoted to using artificial intelligence to help understand climate impacts on biodiversity.   The AI and Biodiversity Change (ABC) Global Climate Center will bring together ecologists and computer scientists from six universities in the United States and Canada, with partners in UK, Europe, and Australia, to develop new AI-enabled, data-supported approaches to study how changes in climate are impacting life – including animals, plants and insects – on Earth.   $5 ...

Ohio State researchers publish national guidelines for ALS genetic testing, counseling

2023-09-18
COLUMBUS, Ohio – Researchers at The Ohio State University Wexner Medical Center and College of Medicine led the creation of evidence-based consensus guidelines for genetic testing and counseling for patients with  amyotrophic lateral sclerosis (ALS), a neurodegenerative disease that affects the cells in the brain and spine. These evidence-based, consensus guidelines provide clinicians with a framework for the offer of genetic testing and outline the information that should be provided to persons with ALS before and after testing. In addition, the guidelines provide specific recommendations regarding ...

Study: Admissions policies that consider grades and test scores in context of available opportunities are linked to college success

2023-09-18
Indicators of high school grades and standardized test scores that take into account the levels of school, neighborhood, and family resources available to students are strongly associated with those students’ success in college, according to new research published today. The study, published in AERA Open, a peer-reviewed journal of the American Educational Research Association, emerges against the backdrop of the recent Supreme Court decision to ban race-conscious admissions in higher ...

Unlocking urban diversity: The magnetism of complex amenities

Unlocking urban diversity: The magnetism of complex amenities
2023-09-18
Diversity fuels prosperity in cities, but where do people from diverse backgrounds meet? A study from the Complexity Science Hub now indicates that locations offering a range of rare shops and services may hold the key.   Extensive research consistently underscores a common factor in successful cities: diversity. Encouraging interactions between individuals of different backgrounds fosters the exchange of ideas, leading to innovation and economic success. “However, segregation persists in urban ...

Latest blood cancer treatment updates presented at annual NCCN event during Blood Cancer Awareness Month

2023-09-18
SAN FRANCISCO, CA [September 18, 2023] — The National Comprehensive Cancer Network® (NCCN®) 2023 Annual Congress: Hematologic Malignancies™ returns to San Francisco this week, for the first time since 2019. The meeting features insights from world-renowned experts on providing optimal, evidence-based treatment for various blood cancers, plus best practices for protecting vulnerable populations in a changing healthcare landscape. The live event is taking place September 22-23, 2023, at the Hilton San Francisco Union Square. ...

LAST 30 PRESS RELEASES:

The research was wrong: study shows moderate drinking won’t lengthen your life

Save your data on printable magnetic devices? New laser technique’s twist might make this reality

Early onset dementia more common than previously reported – the incidence of Alzheimer’s disease seems to be on the rise

Pesticides potentially as bad as smoking for increased risk in certain cancers

NUS researchers develop new battery-free technology to power electronic devices using ambient radiofrequency signals

New protein discovery may influence future cancer treatment

Timing matters: Scripps Research study shows ways to improve health alerts

New gene therapy approach shows promise for Duchenne muscular dystrophy

Chemical analyses find hidden elements from renaissance astronomer Tycho Brahe’s alchemy laboratory

Pacific Northwest launches clean hydrogen energy hub

Tiny deletion in heart muscle protein briefly affects embryonic ventricles but has long-term effects on adult atrial fibrillation

Harms of prescribing NSAIDs to high risk groups estimated to cost NHS £31m over 10 years

Wearing a face mask in public spaces cuts risk of common respiratory symptoms, suggests Norway study

Some private biobanks overinflating the value of umbilical cord blood banking in marketing to expectant parents

New research in fatty liver disease aims to help with early intervention

Genetics reveal ancient trade routes and path to domestication of the Four Corners potato

SNIS 2024: New study shows critical improvements in treating rare eye cancer in children

Wearable devices can increase health anxiety. Could they adversely affect health?

Addressing wounds of war

Rice researchers develop innovative battery recycling method

It’s got praying mantis eyes

Stroke recovery: It’s in the genes

Foam fluidics showcase Rice lab’s creative approach to circuit design

Montana State scientists publish evidence for new groups of methane-producing organisms

Daily rhythms depend on receptor density in biological clock

New England Journal of Medicine publishes outcomes from practice-changing E1910 trial for patients with BCR::ABL1-negative B-cell precursor acute lymphoblastic leukemia

Older adults want to cut back on medication, but study shows need for caution

Nationwide flood models poorly capture risks to households and properties

Does your body composition affect your risk of dementia or Parkinson’s?

Researchers discover faster, more energy-efficient way to manufacture an industrially important chemical

[Press-News.org] Higher buprenorphine doses associated with improved retention in treatment for opioid use disorder
NIH-funded study suggests need to reevaluate opioid addiction treatment recommendations in the era of fentanyl